An estimated 84,100 adolescents and young adults (ages 15–39 years) were diagnosed with cancer in the United States in 2024. Although treatments are becoming more efficacious, they may pose risk
We commend Houeis et al. (1) on their randomized controlled trial suggesting that temsirolimus and antimüllerian hormone (AMH) potentially can protect against chemotherapy-induced ovarian toxicity
Rates of infertility and the demand for assisted reproductive technology continues to rise in the United States. Despite increasing need for highly specialized fertility care, there is a national
Nearly five decades after the birth of the first in vitro fertilization child, the embryology laboratory still depends largely on manual, experience-driven techniques shaped by earlier
To study the association between antimüllerian hormone (AMH) and antral follicle count (AFC) with embryo euploidy rates in patients undergoing in vitro fertilization (IVF) with
To establish the effect of uterine surgery on miscarriage rates. Some surgical procedures risk compromising endometrial function and lead to reproductive dysfunction. There is no long-term data
Live births are the “gold standard” for assessing infertility treatments but are less frequently reported than clinical pregnancy. Identifying approaches to interpret randomized controlled trials
To study whether changing the frozen embryo transfer (FET) protocol for endometrial preparation impacts pregnancy outcomes for women who did not achieve a live birth after their initial FET.
Intrauterine insemination (IUI) is a non-invasive and cost-effective first-line treatment for infertile couples. The pregnancy rate following IUI with ovarian hyperstimulation varies
Frozen-thawed embryo transfers (FET) have become a vital aspect of assisted reproduction. Different aspects affecting clinical outcomes of FET cycles have been studied including the effect of FSH
Displaying 681 to 690 of 2591 records
